Latest filing published 11 Aug 2026 for Ingevity Corp, €113k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Phillip John Platt, listed as senior executive, appears in our data through filings on Ingevity Corp shares, published by SEC (Form 4). Between 27 May 2016 and 10 August 2026, the trades on record add up to 69 filings.
Both buying and selling appear: 1 purchase worth €19k, against 5 sales worth €951k. Sales outweigh purchases by €933k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 60 share grants and 3 option exercises.
On 11 August 2026 came the latest disclosure, a share grant for €113k in Ingevity Corp. The latest purchase dates back some time: it was published 2,416 days ago, on 12 March 2020. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations